West Pharmaceutical Services, Inc. (WST)
305.65
+1.24
(+0.41%)
USD |
NYSE |
May 19, 14:30
West Pharmaceutical Services Research and Development Expense (Quarterly) : 15.80M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Globus Medical, Inc. | 36.51M |
| Repligen Corp. | 14.46M |
| Reflect Scientific, Inc. | 0.0057M |
| Quantum-Si, Inc. | 14.49M |
| Intuitive Surgical, Inc. | 361.60M |